Clinical Trial: Efficacy and Safety of Lonigutamab in Subjects With Thyroid Eye Disease (TED)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Thyroid Eye Disease
Study Type: INTERVENTIONAL
Official Title: A Phase 1/2, Adaptive, Multiple Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Clinical Efficacy of Lonigutamab in Subjects With Thyroid Eye Disease (TED)
Brief Summary:
Phase 1/2, multicenter, multiple dose clinical study designed to evaluate lonigutamab in subjects with TED.
Read more